EE200200653A - alfa-2,4-disulfofenüül-N-tert-butüülnitrooni uuedpreparaadid - Google Patents

alfa-2,4-disulfofenüül-N-tert-butüülnitrooni uuedpreparaadid

Info

Publication number
EE200200653A
EE200200653A EEP200200653A EEP200200653A EE200200653A EE 200200653 A EE200200653 A EE 200200653A EE P200200653 A EEP200200653 A EE P200200653A EE P200200653 A EEP200200653 A EE P200200653A EE 200200653 A EE200200653 A EE 200200653A
Authority
EE
Estonia
Prior art keywords
butylnitrone
disulfophenyl
tert
alpha
new preparations
Prior art date
Application number
EEP200200653A
Other languages
English (en)
Inventor
J. Andersson Mats
Andersson Mattias
Eriksson Patrik
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200200653A publication Critical patent/EE200200653A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200200653A 2000-05-23 2001-05-22 alfa-2,4-disulfofenüül-N-tert-butüülnitrooni uuedpreparaadid EE200200653A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0001916A SE0001916D0 (sv) 2000-05-23 2000-05-23 Novel formulation
PCT/SE2001/001164 WO2001089507A1 (en) 2000-05-23 2001-05-22 NOVEL FORMULATIONS OF α-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE

Publications (1)

Publication Number Publication Date
EE200200653A true EE200200653A (et) 2004-06-15

Family

ID=20279797

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200653A EE200200653A (et) 2000-05-23 2001-05-22 alfa-2,4-disulfofenüül-N-tert-butüülnitrooni uuedpreparaadid

Country Status (29)

Country Link
US (2) US20030181527A1 (et)
EP (1) EP1294369B1 (et)
JP (1) JP3744857B2 (et)
KR (1) KR20030001545A (et)
CN (1) CN1268326C (et)
AR (1) AR030218A1 (et)
AT (1) ATE303803T1 (et)
AU (2) AU2001260935B2 (et)
BR (1) BR0111055A (et)
CA (1) CA2408781A1 (et)
CZ (1) CZ20023849A3 (et)
DE (1) DE60113255T2 (et)
DK (1) DK1294369T3 (et)
EE (1) EE200200653A (et)
ES (1) ES2247112T3 (et)
HU (1) HUP0302310A3 (et)
IL (1) IL152533A0 (et)
IS (1) IS6610A (et)
MX (1) MXPA02011533A (et)
MY (1) MY130445A (et)
NO (1) NO20025461L (et)
NZ (1) NZ522329A (et)
PL (1) PL361284A1 (et)
RU (1) RU2271800C2 (et)
SE (1) SE0001916D0 (et)
SK (1) SK16542002A3 (et)
TW (1) TWI259078B (et)
WO (1) WO2001089507A1 (et)
ZA (1) ZA200208747B (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182060A1 (en) * 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
US9265834B2 (en) 2009-03-05 2016-02-23 Ablynx N.V. Stable formulations of polypeptides and uses thereof
WO2010100135A1 (en) 2009-03-05 2010-09-10 Ablynx N.V. Novel antigen binding dimer-complexes, methods of making/avoiding and uses thereof
AU2010289838C1 (en) * 2009-08-24 2014-03-06 Hough Ear Institute Methods for treating acute acoustic trauma
LT2805731T (lt) * 2009-09-03 2019-02-11 Ablynx N.V. Stabilios polipeptidų kompozicijos ir jų panaudojimas
EP2512489A4 (en) * 2009-12-15 2014-04-02 Merck Sharp & Dohme FORMULATIONS FROM ACADESIN
ES2893825T3 (es) 2011-02-04 2022-02-10 Hough Ear Inst Métodos de tratamiento de lesiones cerebrales
US9669048B2 (en) * 2012-10-25 2017-06-06 Fresenius Kabi Oncology Limited Stable pharmaceutical composition of 5-aza-2′-deoxycitidine
US10660851B2 (en) 2015-01-02 2020-05-26 Rxos Medical Polyfunctional radical scavenger hydrogel formulation
CN116650411A (zh) * 2022-02-25 2023-08-29 广州喜鹊医药有限公司 一种注射用硝酮嗪药物组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0496796B1 (en) * 1989-10-17 1994-08-31 Oklahoma Medical Research Foundation Method and compositions for inhibition of disorders associated with oxidative damage
JP2813023B2 (ja) * 1990-03-13 1998-10-22 株式会社神戸製鋼所 Ｍｉｓ型ダイヤモンド電界効果トランジスタ
US5488145A (en) * 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps

Also Published As

Publication number Publication date
HK1051649A1 (en) 2003-08-15
DE60113255T2 (de) 2006-06-08
CN1268326C (zh) 2006-08-09
JP2003534276A (ja) 2003-11-18
SK16542002A3 (sk) 2003-04-01
CZ20023849A3 (cs) 2003-05-14
CN1430510A (zh) 2003-07-16
NZ522329A (en) 2004-07-30
ATE303803T1 (de) 2005-09-15
NO20025461D0 (no) 2002-11-14
HUP0302310A3 (en) 2005-06-28
IL152533A0 (en) 2003-05-29
RU2271800C2 (ru) 2006-03-20
ZA200208747B (en) 2004-02-10
AU6093501A (en) 2001-12-03
EP1294369B1 (en) 2005-09-07
RU2002129588A (ru) 2004-03-27
TWI259078B (en) 2006-08-01
US20080161406A1 (en) 2008-07-03
BR0111055A (pt) 2003-04-15
SE0001916D0 (sv) 2000-05-23
KR20030001545A (ko) 2003-01-06
AR030218A1 (es) 2003-08-13
ES2247112T3 (es) 2006-03-01
DE60113255D1 (de) 2005-10-13
CA2408781A1 (en) 2001-11-29
PL361284A1 (en) 2004-10-04
US20030181527A1 (en) 2003-09-25
AU2001260935B2 (en) 2005-05-19
MXPA02011533A (es) 2003-04-25
JP3744857B2 (ja) 2006-02-15
HUP0302310A2 (hu) 2003-11-28
DK1294369T3 (da) 2005-11-14
IS6610A (is) 2002-11-11
NO20025461L (no) 2002-11-14
EP1294369A1 (en) 2003-03-26
WO2001089507A1 (en) 2001-11-29
MY130445A (en) 2007-06-29

Similar Documents

Publication Publication Date Title
NO20071303L (no) Farmasoytiske preparater
EP1329217A4 (en) Solid preparations
NO20033556D0 (no) Farmasöytiske preparater
CY2013011I1 (el) Μεθοδος χορηγησης διφωσφονικων
DE50104433D1 (de) Desodorierende Zubereitungen
DE50111817D1 (de) Intrakardiale blutpumpe
DE50113634D1 (de) Parakardiale blutpumpe
DE60119592D1 (de) Turboblutpumpe
DK1210113T3 (da) Kombinerede vaccinepræparater
NO20024170D0 (no) Forminsket, nållös injektor
NO20031483L (no) Vaksine
NO20025450L (no) Ny farmasöytisk sammensetning
ID30590A (id) Celana sekali pakai jenis-celana pendek
ATE391531T1 (de) Schweisshemmende mittel
NO20024172L (no) Vaksine
DE60124356D1 (de) Turboblutpumpe
EP1310252A4 (en) INJECTIONS
DK1278416T3 (da) Flydende præparater
EP1264611A4 (en) SYRINGE
DE50101315D1 (de) Förderpumpe
DE50209245D1 (de) Neuroprotektives medikament
DE60203537D1 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
DE50103731D1 (de) Förderpumpe
IS6610A (is) Nýjar blöndur alfa-2,4-dísúlfófenýl-N-tert-bútýlnítróns
DE10196460T1 (de) Selbstzerstör-Spritze